Ningbo Bio-Mapper Technology Co., Ltd.
Biomapper Technology Co., Ltd. is mainly engaged in the research and development, production and sales of raw materials for in vitro diagnostic reagents. It mainly involves human IVD products, veterinary diagnostics and livestock diagnostics such as sexually transmitted diseases, hepatitis, TORCH&Childhood, tropical&vector-borne diseases, respiratory tract, cancer marker canine diagnostics materials, feline diagnostics materials, swine diagnostics materials, bovine diagnostics materials, small ruminants diagnostics materials and so on.
At the same time, it provides uncut sheet for foreign customers, including, infectious disease, Tropical&vector-borne diseases, respiratory tract, veterinary , livestock diagnostics and other raw materials. From 2020, it saled the SARS-COV-2 antigen or antibody test to many countries. All good feedback. Especially, SARS-COV-2 Antigen test which many companies passed the PEI test and got self-testing list by using our uncut sheets or raw materials.
By fully understanding the market needs and local market rules of each country, the raw materials and uncut sheet have been registered in America, Europe, Africa, Southeast Asia (including Myanmar, Thailand, Laos and Vietnam), and Brazil. The raw materials, including uncut sheets, have been sold to Russia, Canada, Iran, Saudi Arabia, India, South Korea and the Middle East.
Biomapper technology Co., Ltd. promotes lean production, fine management and meticulous service, and promotes leading standards, quality revolution and brand building. Brands with suitable varieties, high quality and good reputation have advantages in the market and have industry standards.
Biomapper adhere to innovation-driven, focus on cultivating and developing strategic emerging industries, transform and upgrade traditional industries, carry out technological innovation, management innovation and business model innovation, cultivate new growth points, and form new competitive advantages.